WIP/CIP and Closed Equipment Systems in the Field of Pharmaceutical Solid Dosage Forms

被引:0
|
作者
Schiffmann, Axel [2 ]
Luy, Bernhard
Leuenberger, Hans [2 ]
Plitzko, Matthias [1 ]
机构
[1] Glatt GmbH, Abt Neue Technol, D-79589 Binzen, Germany
[2] Univ Basel, Pharmazentrum, Basel, Switzerland
来源
PHARMAZEUTISCHE INDUSTRIE | 2009年 / 71卷 / 07期
关键词
Anlagensysteme; Containment; Cleaning in place; Feste Arzneimittelformen; Good Manufacturing Practice; Washing in place; CLEANING VALIDATION;
D O I
暂无
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
In the pharmaceutical industry production equipments for the manufacture of solid dosage forms are cleaned manually, semi- or fully-automated. In order to implement a fully automated cleaning process which meets pharmaceutical (i. e. GMP-)requirements, many conventionally used components must be changed considerably with respect to construction and design. An important aspect is the so-called Total Containment: CIP-ability and Total Containment are interdependent and must be considered equally with the development. The realisation of the Total Containment is an absolute prerequisite for the implementation of this new type of equipment. By the example of a fluid bed system this article describes, how this can be achieved by modifications of conventional equipments and of peripheral devices. The abbreviations WIP/CIP used in this context are clearly defined. WIP (washing in place) means semi- or fully-automated cleaning with either undefined result of cleaning or with the result that the system is not yet clean according to GMP-requirernents. CIP (cleaning in place), on the other hand, stands for the entire process of a fully-autornated cleaning to a GMP-conform level, including all factors, which have influence on the cleaning result. This includes the proof that the acceptance criterion of the cleaning validation was achieved. A comparison study between the manual and fully-automated cleaning shows that by systematic modification of the individual components in connection with a fully-automated cleaning program a higher cleaning grade can be achieved. Furthermore, a statement about the reproducibility of cleaning success can be met.
引用
收藏
页码:1252 / 1259
页数:8
相关论文
共 50 条
  • [31] Porosity measurement of solid pharmaceutical dosage forms by gamma-ray transmission
    de Oliveira, Jose Martins, Jr.
    Andreo Filho, Newton
    Chaud, Marco Vinicius
    Angiolucci, Tatiana
    Aranha, Norberto
    Germano Martins, Antonio Cesar
    APPLIED RADIATION AND ISOTOPES, 2010, 68 (12) : 2223 - 2228
  • [32] Assessment of Applications of Design of Experiments in Pharmaceutical Development for Oral Solid Dosage Forms
    Bai, Ge
    Chen, Zhijin
    Raines, Kimberly
    Chen, Hansong
    Dave, Kaushalkumar
    Lin, Ho-Pi
    Zolnik, Banu S.
    JOURNAL OF PHARMACEUTICAL INNOVATION, 2020, 15 (04) : 547 - 555
  • [33] Compatibility study between chitosan and pharmaceutical excipients used in solid dosage forms
    M. A. V. Pereira
    G. D. Fonseca
    A. A. Silva-Júnior
    M. F. Fernandes-Pedrosa
    M. de F. V. de Moura
    E. G. Barbosa
    A. P. B. Gomes
    K. S. C. R. dos Santos
    Journal of Thermal Analysis and Calorimetry, 2014, 116 : 1091 - 1100
  • [34] Multicomponent Chemical Imaging of Pharmaceutical Solid Dosage Forms with Broadband CARS Microscopy
    Hartshorn, Christopher M.
    Lee, Young Jong
    Camp, Charles H., Jr.
    Liu, Zhen
    Heddleston, John
    Canfield, Nicole
    Rhodes, Timothy A.
    Walker, Angela R. Hight
    Marsac, Patrick J.
    Cicerone, Marcus T.
    ANALYTICAL CHEMISTRY, 2013, 85 (17) : 8102 - 8111
  • [35] Kafirin proteins and their pharmaceutical applications as a novel excipient for solid oral dosage forms
    Georget, D. M. R.
    Eljhalifa, A.
    Barker, S. A.
    Belton, P. S.
    JOURNAL OF PHARMACY AND PHARMACOLOGY, 2008, 60 : A3 - A3
  • [36] Pharmaceutical salts: Theory, use in solid dosage forms and in situ preparation in an aerosol
    Wiedmann, Timothy Scott
    Naqwi, Amir
    ASIAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2016, 11 (06) : 722 - 734
  • [37] Compatibility study between chitosan and pharmaceutical excipients used in solid dosage forms
    Pereira, M. A. V.
    Fonseca, G. D.
    Silva-Junior, A. A.
    Fernandes-Pedrosa, M. F.
    de Moura, M. de F. V.
    Barbosa, E. G.
    Gomes, A. P. B.
    dos Santos, K. S. C. R.
    JOURNAL OF THERMAL ANALYSIS AND CALORIMETRY, 2014, 116 (02) : 1091 - 1100
  • [38] Compatibility study between sitagliptin and pharmaceutical excipients used in solid dosage forms
    Shantikumar, S.
    Sreekanth, G.
    SurendraNath, K. V.
    JaferValli, S.
    Satheeshkumar, N.
    JOURNAL OF THERMAL ANALYSIS AND CALORIMETRY, 2014, 115 (03) : 2423 - 2428
  • [39] Non-destructive determination of anisotropic mechanical properties of pharmaceutical solid dosage forms
    Akseli, I.
    Hancock, B. C.
    Cetinkaya, C.
    INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2009, 377 (1-2) : 35 - 44
  • [40] Detection of surface defects on pharmaceutical solid oral dosage forms with convolutional neural networks
    Racki, Domen
    Tomazevic, Dejan
    Skocaj, Danijel
    NEURAL COMPUTING & APPLICATIONS, 2022, 34 (01): : 631 - 650